BRIEF-Appili Therapeutics Reports Financial And Operational Results For Second Quarter Of Fiscal Year 2022 And Change Of Chief Financial Officer
BRIEF-Appili Therapeutics Reports Financial And Operational Results For Second Quarter Of Fiscal Year 2022 And Change Of Chief Financial Officer
Nov 12 (Reuters) - Appili Therapeutics Inc APLI.TO :
路透11月12日電-Appili Treateutics Inc APLI.TO：
* APPILI THERAPEUTICS REPORTS FINANCIAL AND OPERATIONAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2022 AND CHANGE OF CHIEF FINANCIAL OFFICER
*APPILI Treeutics報告2022財年第二季度的財務和運營業績，並更換首席財務官
* APPILI THERAPEUTICS INC - KENNETH G. HOWLING WILL BE JOINING APPILI THERAPEUTICS AS ACTING CHIEF FINANCIAL OFFICER THIS FALL
*APPILI治療公司-Kenneth G.Howling將於今年秋天加入APPILI治療公司，擔任代理首席財務官
* APPILI THERAPEUTICS INC - KIMBERLY STEPHENS, CO'S CFO HAS CHOSEN TO LEAVE APPILI FOR PERSONAL REASONS EFFECTIVE NOVEMBER 16, 2021
*APPILI治療公司-CO首席財務官金伯利·斯蒂芬斯(Kimberly Stephens)已選擇因個人原因離開APPILI，自2021年11月16日起生效
Source text for Eikon: ID:nBw9xg5Ksa Further company coverage: APLI.TO
Eikon的源文本：ID：nBw9xg5Ksa進一步的公司報道：APLI.TO
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com；)